#USA #Clinical Trial #Nottingham #Perceptive eClinical #Trialzen

Perceptive eClinical and Trialzen Join Forces in Revolutionary Clinical Supply Consultancy

In an exciting development for the clinical trial industry, Perceptive eClinical and Trialzen have announced a new collaboration to launch a technology-enabled clinical supply consultancy. The new service, known as Perceptive Clinical Intelligence, will provide comprehensive support throughout the entire clinical trial lifecycle. This initiative is aimed at tightening the integration of data-driven methodologies and expert-led strategies, ensuring that clinical trials are both efficient and effective in their supply planning and execution.

Perceptive eClinical has been at the forefront of interactive response technology (IRT) and eClinical solutions for over three decades. With deep-rooted expertise in clinical supply management, the company aims to transform its knowledge into a seamlessly integrated service now leveraging Trialzen's advanced planning and analytics technologies. The goal is to optimize clinical supply strategies and empower sponsors with a robust framework to manage decision-making processes.

Understanding Perceptive Clinical Intelligence

At the heart of Perceptive Clinical Intelligence lies an advanced blend of data and human expertise. By merging the clinical supply optimization techniques of Perceptive eClinical with Trialzen’s sophisticated mathematical models, the consultancy aspires to enhance how clinical trials are planned and executed. Unlike traditional methods that often rely on basic tools, this innovative approach focuses on understanding the broader implications of supply decisions on patient outcomes.

Malcolm Morrissey, Head of Perceptive Clinical Intelligence, emphasized the importance of patient-centric strategies in clinical supply management. He points out that decisions made purely on stock levels can overlook critical elements affecting patient care, such as treatment timeliness and site operational confidence. This new service aims to clarify and mitigate risks related to patient continuity and trial visit operations.

Mitigating the Risks of Clinical Trials

Industry data revealing that about 50% of Clinical Finished Goods (CFG) produced for trials remain unused underscores the financial and resource-related inefficiencies prevalent in clinical supply chains. By engaging in this consultancy, sponsors can expect to waste fewer resources and substantially reduce the risk associated with clinical supply logistics.

Shaun Hopgood, Chief Operating Officer at Perceptive eClinical, explains, “Setting up Perceptive Clinical Intelligence is a pivotal evolution, utilizing our rich experience in clinical supply and randomization. Our aim is to drive smarter planning and bolster the overall confidence in clinical supply management across the trial lifecycle.”

The Integration of Technology

The consultancy will benefit from both Perceptive's and Trialzen's tools, bringing proven results from previous collaborations that have realized savings surpassing $1 million and significantly reduced excess supplies. Clients can anticipate several advantages from utilizing this service, including faster study launches, quality decision-making support, and agile adjustments to mid-study forecasts—powered by real-time analytics.

Delivered by seasoned professionals with rich backgrounds in oncology, endocrinology, and infectious diseases, the service is equipped to tackle complex scenarios. This alignment allows for a more significant degree of flexibility and insight than traditional methods provide.

Trialzen’s CEO, Cedric Druck, articulated the foundational principle of their joint efforts. By enabling seamless integration of forecasting and simulation directly into Perceptive's platform, they aspire to bridge the gaps in clinical planning, allowing for a more coherent operational workflow that enhances transparency and instills greater confidence in trial decision-making.

A Future Forward

The collaborative effort aims to foster an environment where strategic supply decisions are consistently aligned with operational actions, facilitating fluid transitions from scenario planning to execution without disruption. Tony Street, Senior Vice President Strategy at Trialzen, echoes the sentiment that such integration will lead to improved visibility and confidence in clinical supply operations.

In conclusion, the alliance between Perceptive eClinical and Trialzen is setting a new standard in the clinical trial supply landscape. With expertise harnessed over years in the industry and an innovative technology-driven approach, the partnership is poised to redefine clinical supply consultancy, delivering enhanced value to sponsors and ultimately improving patient outcomes.

As clinical trials become increasingly intricate, solutions like the Perceptive Clinical Intelligence consultancy underscore the commitment of both Perceptive eClinical and Trialzen to innovation and excellence in supporting the evolving needs of the pharmaceutical and biotechnology industries.